DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 073636
NDA 073636 describes DIPIVEFRIN HYDROCHLORIDE, which is a drug marketed by Bausch And Lomb and Falcon Pharms and is included in two NDAs. Additional details are available on the DIPIVEFRIN HYDROCHLORIDE profile page.
The generic ingredient in DIPIVEFRIN HYDROCHLORIDE is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
The generic ingredient in DIPIVEFRIN HYDROCHLORIDE is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
Summary for 073636
| Tradename: | DIPIVEFRIN HYDROCHLORIDE |
| Applicant: | Falcon Pharms |
| Ingredient: | dipivefrin hydrochloride |
| Patents: | 0 |
| Therapeutic Class: | Ophthalmic Agents |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Jun 30, 1994 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
